Abstract | BACKGROUND: CASE: Products of conception were found in the peritoneal cavity after administration of misoprostol. CONCLUSION: The administration of misoprostol for pregnancy termination should be performed carefully in women with uterine wall defects.
|
Authors | Georgios Lialios, Athanasios Kallitsaris, Jordan Mademtzis, Ioannis E Messinis |
Journal | The Journal of reproductive medicine
(J Reprod Med)
Vol. 51
Issue 7
Pg. 599-600
(Jul 2006)
ISSN: 0024-7758 [Print] United States |
PMID | 16913556
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Abortifacient Agents, Nonsteroidal
- Misoprostol
|
Topics |
- Abortifacient Agents, Nonsteroidal
(adverse effects)
- Abortion, Induced
(adverse effects, methods)
- Adult
- Combined Modality Therapy
- Dilatation and Curettage
(adverse effects)
- Female
- Humans
- Laparoscopy
- Misoprostol
(adverse effects)
- Peritoneal Cavity
(pathology)
- Pregnancy
- Uterus
(injuries, surgery)
|